Safety of celecoxib in patients with adverse reactions to nimesulide.
Liccardi
G
G
Allergy and Respiratory Diseases, Department of Internal Medicine, Pad. Maragliano, L.go R.Benzi 10, 16132 Genoa, Italy.
D'Amato
G
G
Canonica
G W
GW
Lobefalo
G
G
Noschese
P
P
Piccolo
A
A
Salzillo
A
A
Passalacqua
G
G
D000293:Adolescent; D000328:Adult; D000368:Aged; D000799:Angioedema / Q000139:chemically induced; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D000068579:Celecoxib; D004342:Drug Hypersensitivity / Q000209:etiology*; D004890:Erythema / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011720:Pyrazoles / Q000009:adverse effects* / Q000627:therapeutic use; D016037:Single-Blind Method; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use; D014581:Urticaria / Q000139:chemically induced
D000894:Anti-Inflammatory Agents, Non-Steroidal; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib; C012655:nimesulide